Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

163.50p
   
  • Change Today:
      1.50p
  • 52 Week High: 163.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 80,223
  • Market Cap: £174.44m
  • RiskGrade: 515

Cello Health Overview

Cello Health is in the health care sector and is currently trading at 163.50p per share. In the last year Cello Health's share price has ranged from 101.00p to 163.50p and brokers are currently rating this stock as 'neutral'.

Key Personnel

CEO: Mark Scott
Executive Director: Julia Ralston
Group COO: Stephen Highley
Group Finance Director: Mark Bentley
Independent Non-Executive Director: Jo LeCouilliard
Independent Non-Executive Director: Clifford Tompsett
Non-Executive Chairman: Christopher Jones
Non-Executive Dir: Michele Luzi

Contact Details

Address: Queens House, 8-9 Queen Street, London, United Kingdom, EC4N 1SP
Phone: +44 (0)20 7812 8460
Fax: +44 (0)20 7253 5376

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B0310763

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 163.50p
Change Today 1.50p
% Change 0.93 %
52 Week High 163.50
52 Week Low 101.00
Volume 80,223
Shares Issued 106.69m
Market Cap £174.44m
RiskGrade 515

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.81% below the market average67.81% below the market average67.81% below the market average67.81% below the market average67.81% below the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Price Trend
88.19% above the market average88.19% above the market average88.19% above the market average88.19% above the market average88.19% above the market average
35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average
Income
18.66% below the market average18.66% below the market average18.66% below the market average18.66% below the market average18.66% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
31.65% below the market average31.65% below the market average31.65% below the market average31.65% below the market average31.65% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 03-Jul-2020

Time Volume / Share Price
16:20 85,000 @ 163.00p
16:20 85,000 @ 163.00p
15:32 16,900 @ 162.00p
16:07 6,236 @ 162.00p
16:01 67 @ 162.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page